Sort
23,748 grants matching “melanoma”
INVERSE METASTATIC MODALITIES BY HEPARANASES
$132,300Louisiana State Univ A&M Col Baton Rouge · R21 · FY2005 · CA
The role of CD4+ T cells in melanoma immunotherapy
$132,300University Of Virginia Charlottesville · K01 · FY2004 · CA
Investigation of the Wnt/PCP pathway in human malignant melanoma
$132,192Andy J Chien · University Of Washington · K08 · FY2010 · CA
Investigation of the Wnt/PCP pathway in human malignant melanoma
$132,192Andy J Chien · University Of Washington · K08 · FY2007 · CA
Investigation of the Wnt/PCP pathway in human malignant melanoma
$132,192Andy J Chien · University Of Washington · K08 · FY2009 · CA
Investigation of the Wnt/PCP pathway in human malignant melanoma
$132,192Andy J Chien · University Of Washington · K08 · FY2008 · CA
Project 2: Role of codon and isoform differences in Ras tumorigenesis
$132,160Sharon L Campbell · Univ Of North Carolina Chapel Hill · P01 · FY2016 · CA
CANCER AND LEUKEMIA GROUP B
$132,087University Of Missouri-Columbia · U10 · FY2000 · CA
HTS for agents that increase recognition of tumors by cytotoxic lymphocytes
$132,086Timothy J Haggerty · Cytocure, Llc · R43 · FY2007 · CA
Developing New Multicolor Polypeptide MR Contrast Agents for Stem Cell Tracking
$132,039Michael T McMahon · Hugo W. Moser Res Inst Kennedy Krieger · K01 · FY2010 · EB
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma
$132,030Bin Zheng · Beth Israel Deaconess Medical Center · K99 · FY2009 · CA
CANCER AND LEUKEMIA GROUP B
$132,005University Of North Carolina Chapel Hill · U10 · FY2002 · CA
Engineered Optimal Adjuvant and Antigen Release from Biodegradable Nanoparticles
$132,000Aliasger K Salem · University Of Iowa · R21 · FY2009 · CA
Engineered Optimal Adjuvant and Antigen Release from Biodegradable Nanoparticles
$132,000Aliasger K Salem · University Of Iowa · R21 · FY2010 · CA
TARGETING THE ONCOPROTEIN RLIP AS NOVEL THERAPY FOR MELANOMA.
$132,000Beckman Research Institute Of The City Of Hope · · FY2020 · Department of the Army
Insulin Resistance and Colon Cancer in Blacks and Whites
$131,958University Of North Carolina Chapel Hill · K01 · FY2002 · CA
Insulin Resistance and Colon Cancer in Blacks and Whites
$131,958University Of North Carolina Chapel Hill · K01 · FY2003 · CA
REGULATION OF ECM PROTEIN BIOSYNTHESIS IN NORMAL, MALIGNANT AND METASTATIC CELLS
$131,864Howard University · S06 · FY2001 · GM
REGULATION OF ECM PROTEIN BIOSYNTHESIS IN NORMAL, MALIGNANT AND METASTATIC CELLS
$131,864Howard University · S06 · FY2000 · GM
REGULATION OF ECM PROTEIN BIOSYNTHESIS IN NORMAL, MALIGNANT AND METASTATIC CELLS
$131,864Howard University · S06 · FY2001 · GM
REGULATION OF ECM PROTEIN BIOSYNTHESIS IN NORMAL, MALIGNANT AND METASTATIC CELLS
$131,864Howard University · S06 · FY2001 · GM
PROLIFERATIVE CONDITIONING OF TUMOR-COMPETENT DENDRITIC CELL PRECURSORS
$131,805Peter A Cohen · Cleveland Clinic Lerner Com-Cwru · R01 · FY2008 · CA
Regulation of LKB1 and AMPK Signaling by BRAF in Melanoma
$131,790Bin Zheng · Beth Israel Deaconess Medical Center · K99 · FY2008 · CA
Defining the role of Toll-like receptor 3 in skin homeostasis, injury and neoplasia
$131,760Amanda Marie Nelson · Pennsylvania State Univ Hershey Med Ctr · K01 · FY2019 · AR
Defining the role of Toll-like receptor 3 in skin homeostasis, injury and neoplasia
$131,760Amanda Marie Nelson · Pennsylvania State Univ Hershey Med Ctr · K01 · FY2018 · AR